Wei-Chia Lee Selected Research

Wei-Chia Lee Research Topics

Disease

19	Hypertension (High Blood Pressure) 04/2024 - 06/2008
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2023 - 06/2008
6	Inflammation (Inflammations) 05/2024 - 08/2017
5	Pain (Aches) 02/2023 - 10/2009
5	Overactive Urinary Bladder (Overactive Bladder) 01/2023 - 01/2014
4	Cystitis 01/2022 - 08/2017
3	Fibrosis (Cirrhosis) 05/2024 - 11/2019
3	Shock 02/2023 - 08/2017
3	Stroke (Strokes) 01/2023 - 07/2013
3	Dysbiosis 08/2022 - 08/2018
3	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2021 - 10/2009
3	Lower Urinary Tract Symptoms 05/2020 - 11/2012
2	Urinary Incontinence 01/2023 - 10/2009
2	Insulin Resistance 08/2022 - 06/2008
2	Nocturia 05/2020 - 07/2014
2	Infections 01/2020 - 10/2009
2	Hemorrhage 11/2019 - 11/2018
2	Underactive Urinary Bladder 04/2019 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 04/2018 - 07/2013
2	Diabetes Mellitus 01/2013 - 07/2012
1	Fatty Liver 05/2024
1	Non-alcoholic Fatty Liver Disease 05/2024
1	Urinary Tract Infections (Urinary Tract Infection) 04/2023
1	Hypoxia (Hypoxemia) 03/2023
1	Pelvic Pain 02/2023
1	Prostatitis 02/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2023
1	Urinary Retention 01/2023
1	Neuroinflammatory Diseases 10/2022
1	Ischemia 08/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2022
1	Prostatic Neoplasms (Prostate Cancer) 07/2022
1	Chronic Disease (Chronic Diseases) 02/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 09/2021
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 05/2020

Drug/Important Bio-Agent (IBA)

22	FructoseIBA 03/2023 - 06/2008
3	Therapeutic UsesIBA 02/2023 - 01/2023
3	Type A Botulinum Toxins (Botox)FDA Link 01/2023 - 11/2018
3	Liposomes (Liposome)IBA 01/2020 - 10/2009
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2013
3	Uric Acid (Urate)IBA 04/2018 - 07/2013
3	Arachidonic Acid (Vitamin F)IBA 12/2016 - 08/2014
3	C-Reactive ProteinIBA 07/2014 - 04/2012
2	CarbohydratesIBA 04/2024 - 04/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 03/2021
2	Butyrates (Butyrate)IBA 03/2023 - 10/2022
2	AntioxidantsIBA 03/2023 - 10/2022
2	Caspase 3 (Caspase-3)IBA 03/2023 - 01/2022
2	Cytochromes c (Cytochrome c)IBA 03/2023 - 01/2022
2	incobotulinumtoxinA FDA Link 01/2023 - 01/2023
2	Succinic Acid (Succinate)IBA 10/2022 - 08/2022
2	Volatile Fatty AcidsIBA 10/2022 - 03/2021
2	AndrogensIBA 07/2022 - 07/2013
2	Minocycline (Cyclops)FDA LinkGeneric 07/2022 - 03/2021
2	Metformin (Glucophage)FDA LinkGeneric 05/2020 - 04/2018
2	Sirtuin 1IBA 05/2020 - 04/2018
2	Substance PIBA 11/2019 - 11/2018
2	Ketamine FDA LinkGeneric 11/2019 - 11/2018
2	MelatoninIBA 04/2018 - 08/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2018 - 08/2014
2	Nerve Growth Factor (NGF)IBA 08/2017 - 01/2014
2	RNA (Ribonucleic Acid)IBA 01/2016 - 08/2014
2	Serum AlbuminIBA 07/2014 - 07/2012
2	Hemoglobins (Hemoglobin)IBA 07/2014 - 04/2012
2	Streptozocin (Streptozotocin)FDA Link 01/2014 - 01/2013
2	Testosterone (Sustanon)FDA Link 07/2013 - 07/2012
2	Protective AgentsIBA 10/2011 - 10/2009
1	LipidsIBA 05/2024
1	PropionatesIBA 03/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2023
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2023
1	Insulin (Novolin)FDA Link 03/2023
1	CarrageenanIBA 02/2023
1	onabotulinum toxin AIBA 01/2023
1	vinpocetineIBA 10/2022
1	CytokinesIBA 10/2022
1	Celecoxib (Celebrex)FDA Link 10/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2022
1	PrebioticsIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Acetates (Acetic Acid Esters)FDA Link 07/2022
1	Atrial Natriuretic Factor (ANF)IBA 09/2021
1	N-propionylprocainamideIBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	trimethylamineIBA 07/2020
1	DioxinsIBA 07/2020
1	Polychlorinated Dibenzodioxins (TCDD)IBA 07/2020
1	Type 1 Angiotensin ReceptorIBA 05/2020
1	AMP-Activated Protein KinasesIBA 05/2020
1	Simvastatin (Zocor)FDA LinkGeneric 05/2020
1	AngiotensinsIBA 05/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020

Therapy/Procedure

10	Therapeutics 03/2023 - 10/2009
4	Extracorporeal Shockwave Therapy 01/2022 - 08/2017
2	Blood Transfusion (Blood Transfusions) 01/2019 - 03/2010
1	Radiotherapy 07/2022
1	Oral Administration 05/2020